Lorenza Rimassa and Angela Lamarca
Dec 8, 2024, 07:10
Angela Lamarca: MO138 in Biliary Cancer at ESMOAsia24 by Lorenza Rimassa
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on X:
“MO138 in Biliary Cancer at ESMOAsia24 by Lorenza Rimassa.
ProvIDHe: phIIIb – Ivosidenib – mIDH1 (iCCA)
Awaited safety/activity – heavily pretreated (>ClarIDHy)
SOC NGS for IDH (=ClaIDHy (central))
ProvIDHE – 45
Spanish patients could access Ivosidenib.
Funding?”
More posts featuring Angela Lamarca.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 2, 2025, 16:54
May 2, 2025, 15:24
May 2, 2025, 14:52
May 2, 2025, 14:44
May 2, 2025, 14:40